Race, Ethnicity and Donor Type Continue to Affect Survival After Donor Stem Cell Transplant
On Dec. 8, 2025, a study led by Roswell Park Comprehensive Cancer Center reveals that a patient’s race…
Gene expression profiling can accurately diagnose Burkitt’s lymphoma
On Jun. 7, 2006, gene profiling, a molecular technique that examines many genes simultaneously, can accurately distinguish between…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
NCI scientists identified adult patients with non-Hodgkin’s lymphoma likely to be cured by chemotherapy
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
Biotechnology | Disease | FDA | Oncology | Therapeutics
Monoclonal antibody rituximab (Rituxan) approved by the FDA to treat patients with non-Hodgkin lymphoma
On Nov. 26, 1997, the U.S. Food and Drug Administration (FDA) announced it had approved the Monoclonal antibody…
Biotechnology | FDA | Oncology | Therapeutics
Interferon became the first anticancer drug produced through biotechnology
On Jun. 5, 1986, the U.S. Food and Drug Administration (FDA) approved Hoffmann La Roche’s Interferon initially for…